standard]
MENYDILEQIGKGSFGSALLVRHKQEKKKYVLKKIRLARQTDRTRRSAHQ
EMELISKVQNPYIVEYKDSWVERGCYVCIVIGYCEGGDMAEAIKKANGVH
FSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFGL
AKVLTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCMYEMAAHK
PAFKAFDIQGLINKINKSIVSPLPTMYSGPFRGLVKSMLRKNPELRPSAA
DLLRHPHLRPYILNVHLKSNNPRWHTFPSLSSDANFVKKPTAAVKTEKRL
SFGNNRALNPSISGNDLDTPCSSRRAQKSLSHLNDNKFSKLSIGSVGDDV
GVKKLPTTKLSSALRTPRLASAKAPVNPRRQSTPSKISNPGSTRELWVYM
MHMQLPVSHTPARKPAQSTRRASLPLSTRAVPTSSPYKRNVGLLGSVESP
DVSVNAPRIDKMVEFPLASSDDPLLPSRRSSLTSAQCSYASPYGTDRSIT
KDKCMVQILDRTFTRPHSAHGVQYMGSECSEHNPTSGGGSSRSSSDSRQR
RFDTSSYQQRAEALEGLLEFSAQLLQQERFDELQVLLKPFGPEKVSPRET
AIWLTKSFKENVA
|
IPR000719; Protein kinase, catalytic domain IPR002290; Serine/threonine-protein kinase domain IPR008271; Serine/threonine-protein kinase, active site IPR017441; Protein kinase, ATP binding site IPR017 |